Cargando…

Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022

Detalles Bibliográficos
Autores principales:	Clarke, Kristie E.N., Jones, Jefferson M., Deng, Yangyang, Nycz, Elise, Lee, Adam, Iachan, Ronaldo, Gundlapalli, Adi V., Hall, Aron J., MacNeil, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098232/ https://www.ncbi.nlm.nih.gov/pubmed/35482574 http://dx.doi.org/10.15585/mmwr.mm7117e3

Ejemplares similares

Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States—October 25, 2020–February 26, 2022
por: Wiegand, Ryan E., et al.
Publicado: (2022)

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
por: Bajema, Kristina L., et al.
Publicado: (2020)

1356. Case Series of Children with Hepatitis and Adenovirus Infection, Alabama, October 2021—February 2022
por: Buchfellner, Markus A, et al.
Publicado: (2022)

Acute Hepatitis and Adenovirus Infection Among Children — Alabama, October 2021–February 2022
por: Baker, Julia M., et al.
Publicado: (2022)

Disparities in COVID-19 Vaccine Booster Uptake in the USA: December 2021–February 2022
por: Gaffney, Adam, et al.
Publicado: (2022)

In This Issue: February 2021
por: DeJong, Sandra M., et al.
Publicado: (2021)

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies in Republic of Congo, February 2022
por: Ndziessi, Gilbert, et al.
Publicado: (2023)

460. SARS-CoV-2 Infection-Induced Antibody Seroprevalence in Previously Infected Persons with Immunocompromising Conditions — United States, 2020–2022
por: Bratcher, Anna, et al.
Publicado: (2023)

Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021–February 2022
por: Sofonea, Mircea T., et al.
Publicado: (2022)

Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021
por: Steele, Molly K., et al.
Publicado: (2022)

Characterisation of COVID-19 deaths by vaccination types and status in Malaysia between February and September 2021
por: Abdul Taib, Nur Asheila, et al.
Publicado: (2022)

Spatiotemporal analysis of the morbidity of global Omicron from November 2021 to February 2022
por: Liang, Yuelang, et al.
Publicado: (2022)

Does the COVID-19 Vaccination Rate Change According to the Education and Income: A Study on Vaccination Rates in Cities of Turkey between 2021-September and 2022-February
por: Cengiz, Beyza, et al.
Publicado: (2022)

Human vaccines & immunotherapeutics: News September 2022
por: Ellis, Ronald, et al.
Publicado: (2022)

In the Limelight: February 2022
por: Nath, Karl A.
Publicado: (2022)

In the literature: February 2022
por: Gambardella, V., et al.
Publicado: (2022)

Progress Toward Poliomyelitis Eradication ― Afghanistan, January 2021–September 2022
por: Mohamed, Abdinoor, et al.
Publicado: (2022)

Characterizing the evolving SARS-CoV-2 seroprevalence in urban and rural Malawi between February 2021 and April 2022: A population-based cohort study
por: Banda, Louis, et al.
Publicado: (2023)

Mental Health and Substance Use Among Adults with Disabilities During the COVID-19 Pandemic — United States, February–March 2021
por: Czeisler, Mark É., et al.
Publicado: (2021)

In the literature: February 2021
por: Cejalvo, J.M., et al.
Publicado: (2021)

In the Limelight: February 2021
por: Nath, Karl A.
Publicado: (2021)

U.S. CDC support to international SARS-CoV-2 seroprevalence surveys, May 2020–February 2022
por: Ben Hamida, Amen, et al.
Publicado: (2022)

National weighting of data from the Behavioral Risk Factor Surveillance System (BRFSS)
por: Iachan, Ronaldo, et al.
Publicado: (2016)

Seroprevalence of Toxoplasma gondii among Pregnant Women in Ardabil, Iran (2021–2022)
por: Sadegi Hariri, Sahar, et al.
Publicado: (2023)

Ventilation Improvement Strategies Among K–12 Public Schools — The National School COVID-19 Prevention Study, United States, February 14–March 27, 2022
por: Pampati, Sanjana, et al.
Publicado: (2022)

Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022
por: Chung, Jessie R., et al.
Publicado: (2022)

Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status — United States, April 2021–September 2022
por: Jones, Jefferson M., et al.
Publicado: (2023)

In the Limelight: September 2022
por: Nath, Karl A.
Publicado: (2022)

Acknowledging the peer reviewers of Journal of Medical Radiation Sciences, October 2021 – September 2022
Publicado: (2022)

Widespread Community Transmission of Hepatitis A Virus Following an Outbreak at a Local Restaurant — Virginia, September 2021–September 2022
por: Helmick, Meagan J., et al.
Publicado: (2023)

Microbial Musings – February 2021
por: Thomas, Gavin H.
Publicado: (2021)

Real-world treatment patterns and clinical outcomes for inpatients with COVID-19 in the US from September 2020 to February 2021
por: Ayodele, Olulade, et al.
Publicado: (2021)

Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022
por: Bastard, Jonathan, et al.
Publicado: (2022)

Circulating Dynamics of SARS-CoV-2 Variants between April 2021 and February 2022 in Turkey
por: Sayan, Murat, et al.
Publicado: (2022)

Safety monitoring of COVID-19 vaccines: February 26, 2021, To June 4, 2022, Republic of Korea
por: Lee, Yeon-Kyeng, et al.
Publicado: (2023)

PRAC meeting highlights February 2022
Publicado: (2022)

Introduction to the September 2022 Issue
por: Hodges, Charles B.
Publicado: (2022)

Editors’ Message September 2022
por: Michos, Erin D., et al.
Publicado: (2022)

One year of SARS-CoV-2 circulation in the Nouvelle-Aquitaine region, February 2021–2022, France
por: Deroche, Luc, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ii3rs6ugh6jdsq48c5tdaci1dj